ARQ 197

tivantinib · ArQule, Inc.

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for ARQ 197, covering 2008-06-19 to 2022-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Pazopanib and ARQ 197 for Advanced Solid Tumors [Phase 1]